{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:41:00Z","timestamp":1761896460729},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1097\/md.0000000000005787","type":"journal-article","created":{"date-parts":[[2017,1,10]],"date-time":"2017-01-10T17:34:43Z","timestamp":1484069683000},"page":"e5787","source":"Crossref","is-referenced-by-count":9,"title":["Bortezomib combined with lenalidomide as the first-line treatment for the rare synchronous occurrence of multiple myeloma and pulmonary adenocarcinoma"],"prefix":"10.1097","volume":"96","author":[{"given":"Wenli","family":"Zuo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinghu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingke","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenyang","family":"Mei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quande","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongping","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingsong","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-50-20210226","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1046\/j.1365-2141.2003.04355.x","article-title":"Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group","volume":"121","author":"Robert","year":"2003","journal-title":"Br J Haematol"},{"key":"R2-50-20210226","doi-asserted-by":"crossref","first-page":"338","DOI":"10.4143\/crt.2004.36.5.338","article-title":"Three cases of synchronous solid tumor and multiple myeloma","volume":"36","author":"Ji","year":"2004","journal-title":"Cancer Res Treat"},{"key":"R3-50-20210226","first-page":"64","article-title":"A case of a combination of multiple myeloma and lung cancer","volume":"69","author":"Osipova","year":"1997","journal-title":"Ter Arkh"},{"key":"R4-50-20210226","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.2169\/internalmedicine.49.3996","article-title":"Autologous cytokine-induced killer cells in the treatment of multiple myeloma concomitant with lung cancer and paraneoplastic dermatoses","volume":"49","author":"Lin","year":"2010","journal-title":"Intern Med (Tokyo, Japan"},{"key":"R5-50-20210226","doi-asserted-by":"crossref","first-page":"5814","DOI":"10.1200\/JCO.2008.19.6287","article-title":"Synchronous presentation of multiple myeloma and lung cancer","volume":"26","author":"Agarwal","year":"2008","journal-title":"J Clin Oncol"},{"key":"R6-50-20210226","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1510\/icvts.2009.230854","article-title":"Definitive diagnosis of multiple myeloma from rib specimens resected at thoracotomy in a patient with lung cancer","volume":"10","author":"Goto","year":"2010","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"R7-50-20210226","first-page":"239","article-title":"Patients with multiple myeloma and solid tumors: six case reports","volume":"17","author":"Christou","year":"1998","journal-title":"J Exp Clin Cancer Res"},{"key":"R8-50-20210226","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ajh.1067","article-title":"Clinical and pathologic findings in 52 consecutively autopsied cases with multiple myeloma","volume":"67","author":"Oshima","year":"2001","journal-title":"Am J Hematol"},{"key":"R9-50-20210226","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4065\/78.1.21","article-title":"Review of 1027 patients with newly diagnosed multiple myeloma","volume":"78","author":"Kyle","year":"2003","journal-title":"Mayo Clin Proc"},{"key":"R10-50-20210226","first-page":"4038","article-title":"Infectious and noninfectious exposures in the etiology of light chain myeloma: a case-control study","volume":"49","author":"Williams","year":"1989","journal-title":"Cancer Res"},{"key":"R11-50-20210226","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1038\/sj.bjc.6690247","article-title":"Discrimination of double primary lung cancer from intrapulmonary metastasis by p53 gene mutation","volume":"79","author":"Matsuzoe","year":"1999","journal-title":"Br J Cancer"},{"key":"R12-50-20210226","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/S0003-4975(98)00177-5","article-title":"Multiple primary cancers in esophageal squamous cell carcinoma: incidence and implications","volume":"65","author":"Poon","year":"1998","journal-title":"Ann Thorac Surg"},{"key":"R13-50-20210226","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.3816\/CLC.2005.s.011","article-title":"The potential role of bortezomib in combination with chemotherapy and radiation in non-small-cell lung cancer","volume":"7","author":"Edelman","year":"2005","journal-title":"Clin Lung Cancer"},{"key":"R14-50-20210226","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1097\/JTO.0b013e31824de2fa","article-title":"Phase-I\/II study of bortezomib in combination with carboplatin and bevacizumab as first-line therapy in patients with advanced non-small-cell lung cancer","volume":"7","author":"Piperdi","year":"2012","journal-title":"J Thorac Oncol"},{"key":"R15-50-20210226","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1517\/13543784.15.2.171","article-title":"Current therapeutic uses of lenalidomide in multiple myeloma","volume":"15","author":"Hideshima","year":"2006","journal-title":"Expert Opin Investig Drugs"},{"key":"R16-50-20210226","doi-asserted-by":"crossref","first-page":"588","DOI":"10.3892\/ol.2012.1054","article-title":"Lenalidomide induces apoptosis and alters gene expression in non-small cell lung cancer cells","volume":"5","author":"Kim","year":"2013","journal-title":"Oncol Lett"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000005787","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:41:15Z","timestamp":1620960075000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201701060-00050"}},"subtitle":["A case report"],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000005787","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]}}}